Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

Dates: 2005 – 2009 Country:

You searched for subject:( Tradi o discursiva). Showing records 1 – 10 of 10 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


Universiteit Utrecht

1. Bruijnincx, P.C.A. Structural and Functional Models of Non-Heme Iron Enzymes : A Study of the 2-His-1-Carboxylate Facial Triad Structural Motif.

Degree: 2007, Universiteit Utrecht

 The structural and functional modeling of a specific group of non-heme iron enzymes by the synthesis of small synthetic analogues is the topic of this… (more)

Subjects/Keywords: Scheikunde; bioinorganic chemistry; non-heme iron enzymes; 2-His-1-carboxylate facial triad; N,N,O ligands; small synthetic analogues; oxidation catalysis; epoxidation; cis-dihydroxylation; copper; zinc

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bruijnincx, P. C. A. (2007). Structural and Functional Models of Non-Heme Iron Enzymes : A Study of the 2-His-1-Carboxylate Facial Triad Structural Motif. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/19232

Chicago Manual of Style (16th Edition):

Bruijnincx, P C A. “Structural and Functional Models of Non-Heme Iron Enzymes : A Study of the 2-His-1-Carboxylate Facial Triad Structural Motif.” 2007. Doctoral Dissertation, Universiteit Utrecht. Accessed December 12, 2019. http://dspace.library.uu.nl:8080/handle/1874/19232.

MLA Handbook (7th Edition):

Bruijnincx, P C A. “Structural and Functional Models of Non-Heme Iron Enzymes : A Study of the 2-His-1-Carboxylate Facial Triad Structural Motif.” 2007. Web. 12 Dec 2019.

Vancouver:

Bruijnincx PCA. Structural and Functional Models of Non-Heme Iron Enzymes : A Study of the 2-His-1-Carboxylate Facial Triad Structural Motif. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2007. [cited 2019 Dec 12]. Available from: http://dspace.library.uu.nl:8080/handle/1874/19232.

Council of Science Editors:

Bruijnincx PCA. Structural and Functional Models of Non-Heme Iron Enzymes : A Study of the 2-His-1-Carboxylate Facial Triad Structural Motif. [Doctoral Dissertation]. Universiteit Utrecht; 2007. Available from: http://dspace.library.uu.nl:8080/handle/1874/19232


Universiteit Utrecht

2. Schooten, C.J.M. van. Von Willebrand Factor: clearance as regulator of plasma levels.

Degree: 2007, Universiteit Utrecht

 Von Willebrand factor (VWF) and coagulation factor VIII (FVIII) are plasma proteins that circulate in a tight, noncovalent complex. Binding to VWF is required to… (more)

Subjects/Keywords: Geneeskunde; Von Willebrand Factor; Von Willebrand Disease; O-linked glycosylation; cysteine mutations; clearance mechanism; factor VIII; Von Willebrand factor/factor VIII complex; half-life; macrophages; Staphylococcus aureus protein A

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Schooten, C. J. M. v. (2007). Von Willebrand Factor: clearance as regulator of plasma levels. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/23898

Chicago Manual of Style (16th Edition):

Schooten, C J M van. “Von Willebrand Factor: clearance as regulator of plasma levels.” 2007. Doctoral Dissertation, Universiteit Utrecht. Accessed December 12, 2019. http://dspace.library.uu.nl:8080/handle/1874/23898.

MLA Handbook (7th Edition):

Schooten, C J M van. “Von Willebrand Factor: clearance as regulator of plasma levels.” 2007. Web. 12 Dec 2019.

Vancouver:

Schooten CJMv. Von Willebrand Factor: clearance as regulator of plasma levels. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2007. [cited 2019 Dec 12]. Available from: http://dspace.library.uu.nl:8080/handle/1874/23898.

Council of Science Editors:

Schooten CJMv. Von Willebrand Factor: clearance as regulator of plasma levels. [Doctoral Dissertation]. Universiteit Utrecht; 2007. Available from: http://dspace.library.uu.nl:8080/handle/1874/23898

3. Karawajczyk, Anna. Chemical activity of anticancer compounds: computational studies on the mechanism of bleomycin and the recognition of flavonoids.

Degree: 2007, LIC/SSNMR, Faculty of Science, Leiden University

 The thesis is focused on the DNA-cleaving antibiotic bleomycin that is successfully used in the chemotherapy against several types of cancer like head and neck… (more)

Subjects/Keywords: Bleomycin; Density Functional Theory; Drug-DNA interactions; First principles Molecular Dynamics; Ligands of bilitranslocase; O-O bond cleavage; QM/MM; Bleomycin; Density Functional Theory; Drug-DNA interactions; First principles Molecular Dynamics; Ligands of bilitranslocase; O-O bond cleavage; QM/MM

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Karawajczyk, A. (2007). Chemical activity of anticancer compounds: computational studies on the mechanism of bleomycin and the recognition of flavonoids. (Doctoral Dissertation). LIC/SSNMR, Faculty of Science, Leiden University. Retrieved from http://hdl.handle.net/1887/12409

Chicago Manual of Style (16th Edition):

Karawajczyk, Anna. “Chemical activity of anticancer compounds: computational studies on the mechanism of bleomycin and the recognition of flavonoids.” 2007. Doctoral Dissertation, LIC/SSNMR, Faculty of Science, Leiden University. Accessed December 12, 2019. http://hdl.handle.net/1887/12409.

MLA Handbook (7th Edition):

Karawajczyk, Anna. “Chemical activity of anticancer compounds: computational studies on the mechanism of bleomycin and the recognition of flavonoids.” 2007. Web. 12 Dec 2019.

Vancouver:

Karawajczyk A. Chemical activity of anticancer compounds: computational studies on the mechanism of bleomycin and the recognition of flavonoids. [Internet] [Doctoral dissertation]. LIC/SSNMR, Faculty of Science, Leiden University; 2007. [cited 2019 Dec 12]. Available from: http://hdl.handle.net/1887/12409.

Council of Science Editors:

Karawajczyk A. Chemical activity of anticancer compounds: computational studies on the mechanism of bleomycin and the recognition of flavonoids. [Doctoral Dissertation]. LIC/SSNMR, Faculty of Science, Leiden University; 2007. Available from: http://hdl.handle.net/1887/12409


Universiteit Utrecht

4. Muntjewerff, J.W. Homocysteine metabolism and risk of schizophrenia.

Degree: 2006, Universiteit Utrecht

 The one-carbon cycle hypothesis initiated research of schizophrenia risk in relation to sensitive markers of aberrant homocysteine metabolism, such as B-vitamin concentrations, plasma total homocysteine… (more)

Subjects/Keywords: Geneeskunde; homocysteine; folate; B-vitamins; schizophrenia; genetics; methylenetetrahydrofolate reductase; catechol-O-methyltransferase; methylation; psychiatric disorders; neurodevelopment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Muntjewerff, J. W. (2006). Homocysteine metabolism and risk of schizophrenia. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/14032

Chicago Manual of Style (16th Edition):

Muntjewerff, J W. “Homocysteine metabolism and risk of schizophrenia.” 2006. Doctoral Dissertation, Universiteit Utrecht. Accessed December 12, 2019. http://dspace.library.uu.nl:8080/handle/1874/14032.

MLA Handbook (7th Edition):

Muntjewerff, J W. “Homocysteine metabolism and risk of schizophrenia.” 2006. Web. 12 Dec 2019.

Vancouver:

Muntjewerff JW. Homocysteine metabolism and risk of schizophrenia. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2006. [cited 2019 Dec 12]. Available from: http://dspace.library.uu.nl:8080/handle/1874/14032.

Council of Science Editors:

Muntjewerff JW. Homocysteine metabolism and risk of schizophrenia. [Doctoral Dissertation]. Universiteit Utrecht; 2006. Available from: http://dspace.library.uu.nl:8080/handle/1874/14032


Vrije Universiteit Amsterdam

5. Verhoeven, M.O. Menopause, menopausal therapies and asymmetric dimethylarginine, an emerging cardiovascular risk factor .

Degree: 2007, Vrije Universiteit Amsterdam

 Oestrogenen en asymmetrische dimethylarginine Hart- en vaatziekten (HVZ) vormen de belangrijkste doodsoorzaak in de Westerse wereld. Premenopauzale vrouwen hebben een lager risico op HVZ dan… (more)

Subjects/Keywords: Menopausal therapy and asymmetric dimethylarginine; Menopause; Menopausal therapies; asymmetric dimethylarginine; cardiovascular risk factor; (o)estradiol

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Verhoeven, M. O. (2007). Menopause, menopausal therapies and asymmetric dimethylarginine, an emerging cardiovascular risk factor . (Doctoral Dissertation). Vrije Universiteit Amsterdam. Retrieved from http://hdl.handle.net/1871/12930

Chicago Manual of Style (16th Edition):

Verhoeven, M O. “Menopause, menopausal therapies and asymmetric dimethylarginine, an emerging cardiovascular risk factor .” 2007. Doctoral Dissertation, Vrije Universiteit Amsterdam. Accessed December 12, 2019. http://hdl.handle.net/1871/12930.

MLA Handbook (7th Edition):

Verhoeven, M O. “Menopause, menopausal therapies and asymmetric dimethylarginine, an emerging cardiovascular risk factor .” 2007. Web. 12 Dec 2019.

Vancouver:

Verhoeven MO. Menopause, menopausal therapies and asymmetric dimethylarginine, an emerging cardiovascular risk factor . [Internet] [Doctoral dissertation]. Vrije Universiteit Amsterdam; 2007. [cited 2019 Dec 12]. Available from: http://hdl.handle.net/1871/12930.

Council of Science Editors:

Verhoeven MO. Menopause, menopausal therapies and asymmetric dimethylarginine, an emerging cardiovascular risk factor . [Doctoral Dissertation]. Vrije Universiteit Amsterdam; 2007. Available from: http://hdl.handle.net/1871/12930

6. Muntjewerff, J.W. Homocysteine metabolism and risk of schizophrenia.

Degree: 2006, University Utrecht

 The one-carbon cycle hypothesis initiated research of schizophrenia risk in relation to sensitive markers of aberrant homocysteine metabolism, such as B-vitamin concentrations, plasma total homocysteine… (more)

Subjects/Keywords: homocysteine; folate; B-vitamins; schizophrenia; genetics; methylenetetrahydrofolate reductase; catechol-O-methyltransferase; methylation; psychiatric disorders; neurodevelopment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Muntjewerff, J. W. (2006). Homocysteine metabolism and risk of schizophrenia. (Doctoral Dissertation). University Utrecht. Retrieved from http://dspace.library.uu.nl/handle/1874/14032 ; URN:NBN:NL:UI:10-1874-14032 ; urn:isbn:90-9021133-0 ; URN:NBN:NL:UI:10-1874-14032 ; http://dspace.library.uu.nl/handle/1874/14032

Chicago Manual of Style (16th Edition):

Muntjewerff, J W. “Homocysteine metabolism and risk of schizophrenia.” 2006. Doctoral Dissertation, University Utrecht. Accessed December 12, 2019. http://dspace.library.uu.nl/handle/1874/14032 ; URN:NBN:NL:UI:10-1874-14032 ; urn:isbn:90-9021133-0 ; URN:NBN:NL:UI:10-1874-14032 ; http://dspace.library.uu.nl/handle/1874/14032.

MLA Handbook (7th Edition):

Muntjewerff, J W. “Homocysteine metabolism and risk of schizophrenia.” 2006. Web. 12 Dec 2019.

Vancouver:

Muntjewerff JW. Homocysteine metabolism and risk of schizophrenia. [Internet] [Doctoral dissertation]. University Utrecht; 2006. [cited 2019 Dec 12]. Available from: http://dspace.library.uu.nl/handle/1874/14032 ; URN:NBN:NL:UI:10-1874-14032 ; urn:isbn:90-9021133-0 ; URN:NBN:NL:UI:10-1874-14032 ; http://dspace.library.uu.nl/handle/1874/14032.

Council of Science Editors:

Muntjewerff JW. Homocysteine metabolism and risk of schizophrenia. [Doctoral Dissertation]. University Utrecht; 2006. Available from: http://dspace.library.uu.nl/handle/1874/14032 ; URN:NBN:NL:UI:10-1874-14032 ; urn:isbn:90-9021133-0 ; URN:NBN:NL:UI:10-1874-14032 ; http://dspace.library.uu.nl/handle/1874/14032

7. Muntjewerff, J.W. Homocysteine metabolism and risk of schizophrenia.

Degree: 2006, University Utrecht

 The one-carbon cycle hypothesis initiated research of schizophrenia risk in relation to sensitive markers of aberrant homocysteine metabolism, such as B-vitamin concentrations, plasma total homocysteine… (more)

Subjects/Keywords: homocysteine; folate; B-vitamins; schizophrenia; genetics; methylenetetrahydrofolate reductase; catechol-O-methyltransferase; methylation; psychiatric disorders; neurodevelopment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Muntjewerff, J. W. (2006). Homocysteine metabolism and risk of schizophrenia. (Doctoral Dissertation). University Utrecht. Retrieved from http://dspace.library.uu.nl/handle/1874/14032 ; URN:NBN:NL:UI:10-1874-14032 ; urn:isbn:90-9021133-0 ; URN:NBN:NL:UI:10-1874-14032 ; http://dspace.library.uu.nl/handle/1874/14032

Chicago Manual of Style (16th Edition):

Muntjewerff, J W. “Homocysteine metabolism and risk of schizophrenia.” 2006. Doctoral Dissertation, University Utrecht. Accessed December 12, 2019. http://dspace.library.uu.nl/handle/1874/14032 ; URN:NBN:NL:UI:10-1874-14032 ; urn:isbn:90-9021133-0 ; URN:NBN:NL:UI:10-1874-14032 ; http://dspace.library.uu.nl/handle/1874/14032.

MLA Handbook (7th Edition):

Muntjewerff, J W. “Homocysteine metabolism and risk of schizophrenia.” 2006. Web. 12 Dec 2019.

Vancouver:

Muntjewerff JW. Homocysteine metabolism and risk of schizophrenia. [Internet] [Doctoral dissertation]. University Utrecht; 2006. [cited 2019 Dec 12]. Available from: http://dspace.library.uu.nl/handle/1874/14032 ; URN:NBN:NL:UI:10-1874-14032 ; urn:isbn:90-9021133-0 ; URN:NBN:NL:UI:10-1874-14032 ; http://dspace.library.uu.nl/handle/1874/14032.

Council of Science Editors:

Muntjewerff JW. Homocysteine metabolism and risk of schizophrenia. [Doctoral Dissertation]. University Utrecht; 2006. Available from: http://dspace.library.uu.nl/handle/1874/14032 ; URN:NBN:NL:UI:10-1874-14032 ; urn:isbn:90-9021133-0 ; URN:NBN:NL:UI:10-1874-14032 ; http://dspace.library.uu.nl/handle/1874/14032

8. Bruijnincx, P.C.A. Structural and Functional Models of Non-Heme Iron Enzymes : A Study of the 2-His-1-Carboxylate Facial Triad Structural Motif.

Degree: 2007, University Utrecht

 The structural and functional modeling of a specific group of non-heme iron enzymes by the synthesis of small synthetic analogues is the topic of this… (more)

Subjects/Keywords: bioinorganic chemistry; non-heme iron enzymes; 2-His-1-carboxylate facial triad; N,N,O ligands; small synthetic analogues; oxidation catalysis; epoxidation; cis-dihydroxylation; copper; zinc

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bruijnincx, P. C. A. (2007). Structural and Functional Models of Non-Heme Iron Enzymes : A Study of the 2-His-1-Carboxylate Facial Triad Structural Motif. (Doctoral Dissertation). University Utrecht. Retrieved from http://dspace.library.uu.nl/handle/1874/19232 ; URN:NBN:NL:UI:10-1874-19232 ; urn:isbn:978-90-393-4438-5 ; URN:NBN:NL:UI:10-1874-19232 ; http://dspace.library.uu.nl/handle/1874/19232

Chicago Manual of Style (16th Edition):

Bruijnincx, P C A. “Structural and Functional Models of Non-Heme Iron Enzymes : A Study of the 2-His-1-Carboxylate Facial Triad Structural Motif.” 2007. Doctoral Dissertation, University Utrecht. Accessed December 12, 2019. http://dspace.library.uu.nl/handle/1874/19232 ; URN:NBN:NL:UI:10-1874-19232 ; urn:isbn:978-90-393-4438-5 ; URN:NBN:NL:UI:10-1874-19232 ; http://dspace.library.uu.nl/handle/1874/19232.

MLA Handbook (7th Edition):

Bruijnincx, P C A. “Structural and Functional Models of Non-Heme Iron Enzymes : A Study of the 2-His-1-Carboxylate Facial Triad Structural Motif.” 2007. Web. 12 Dec 2019.

Vancouver:

Bruijnincx PCA. Structural and Functional Models of Non-Heme Iron Enzymes : A Study of the 2-His-1-Carboxylate Facial Triad Structural Motif. [Internet] [Doctoral dissertation]. University Utrecht; 2007. [cited 2019 Dec 12]. Available from: http://dspace.library.uu.nl/handle/1874/19232 ; URN:NBN:NL:UI:10-1874-19232 ; urn:isbn:978-90-393-4438-5 ; URN:NBN:NL:UI:10-1874-19232 ; http://dspace.library.uu.nl/handle/1874/19232.

Council of Science Editors:

Bruijnincx PCA. Structural and Functional Models of Non-Heme Iron Enzymes : A Study of the 2-His-1-Carboxylate Facial Triad Structural Motif. [Doctoral Dissertation]. University Utrecht; 2007. Available from: http://dspace.library.uu.nl/handle/1874/19232 ; URN:NBN:NL:UI:10-1874-19232 ; urn:isbn:978-90-393-4438-5 ; URN:NBN:NL:UI:10-1874-19232 ; http://dspace.library.uu.nl/handle/1874/19232

9. Schooten, C.J.M. van. Von Willebrand Factor: clearance as regulator of plasma levels.

Degree: 2007, University Utrecht

 Von Willebrand factor (VWF) and coagulation factor VIII (FVIII) are plasma proteins that circulate in a tight, noncovalent complex. Binding to VWF is required to… (more)

Subjects/Keywords: Von Willebrand Factor; Von Willebrand Disease; O-linked glycosylation; cysteine mutations; clearance mechanism; factor VIII; Von Willebrand factor/factor VIII complex; half-life; macrophages; Staphylococcus aureus protein A

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Schooten, C. J. M. v. (2007). Von Willebrand Factor: clearance as regulator of plasma levels. (Doctoral Dissertation). University Utrecht. Retrieved from http://dspace.library.uu.nl/handle/1874/23898 ; URN:NBN:NL:UI:10-1874-23898 ; urn:isbn:978-90-393-4649-5 ; URN:NBN:NL:UI:10-1874-23898 ; http://dspace.library.uu.nl/handle/1874/23898

Chicago Manual of Style (16th Edition):

Schooten, C J M van. “Von Willebrand Factor: clearance as regulator of plasma levels.” 2007. Doctoral Dissertation, University Utrecht. Accessed December 12, 2019. http://dspace.library.uu.nl/handle/1874/23898 ; URN:NBN:NL:UI:10-1874-23898 ; urn:isbn:978-90-393-4649-5 ; URN:NBN:NL:UI:10-1874-23898 ; http://dspace.library.uu.nl/handle/1874/23898.

MLA Handbook (7th Edition):

Schooten, C J M van. “Von Willebrand Factor: clearance as regulator of plasma levels.” 2007. Web. 12 Dec 2019.

Vancouver:

Schooten CJMv. Von Willebrand Factor: clearance as regulator of plasma levels. [Internet] [Doctoral dissertation]. University Utrecht; 2007. [cited 2019 Dec 12]. Available from: http://dspace.library.uu.nl/handle/1874/23898 ; URN:NBN:NL:UI:10-1874-23898 ; urn:isbn:978-90-393-4649-5 ; URN:NBN:NL:UI:10-1874-23898 ; http://dspace.library.uu.nl/handle/1874/23898.

Council of Science Editors:

Schooten CJMv. Von Willebrand Factor: clearance as regulator of plasma levels. [Doctoral Dissertation]. University Utrecht; 2007. Available from: http://dspace.library.uu.nl/handle/1874/23898 ; URN:NBN:NL:UI:10-1874-23898 ; urn:isbn:978-90-393-4649-5 ; URN:NBN:NL:UI:10-1874-23898 ; http://dspace.library.uu.nl/handle/1874/23898

10. Schooten, C.J.M. van. Von Willebrand Factor: clearance as regulator of plasma levels.

Degree: 2007, University Utrecht

 Von Willebrand factor (VWF) and coagulation factor VIII (FVIII) are plasma proteins that circulate in a tight, noncovalent complex. Binding to VWF is required to… (more)

Subjects/Keywords: Von Willebrand Factor; Von Willebrand Disease; O-linked glycosylation; cysteine mutations; clearance mechanism; factor VIII; Von Willebrand factor/factor VIII complex; half-life; macrophages; Staphylococcus aureus protein A

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Schooten, C. J. M. v. (2007). Von Willebrand Factor: clearance as regulator of plasma levels. (Doctoral Dissertation). University Utrecht. Retrieved from http://dspace.library.uu.nl/handle/1874/23898 ; URN:NBN:NL:UI:10-1874-23898 ; urn:isbn:978-90-393-4649-5 ; URN:NBN:NL:UI:10-1874-23898 ; http://dspace.library.uu.nl/handle/1874/23898

Chicago Manual of Style (16th Edition):

Schooten, C J M van. “Von Willebrand Factor: clearance as regulator of plasma levels.” 2007. Doctoral Dissertation, University Utrecht. Accessed December 12, 2019. http://dspace.library.uu.nl/handle/1874/23898 ; URN:NBN:NL:UI:10-1874-23898 ; urn:isbn:978-90-393-4649-5 ; URN:NBN:NL:UI:10-1874-23898 ; http://dspace.library.uu.nl/handle/1874/23898.

MLA Handbook (7th Edition):

Schooten, C J M van. “Von Willebrand Factor: clearance as regulator of plasma levels.” 2007. Web. 12 Dec 2019.

Vancouver:

Schooten CJMv. Von Willebrand Factor: clearance as regulator of plasma levels. [Internet] [Doctoral dissertation]. University Utrecht; 2007. [cited 2019 Dec 12]. Available from: http://dspace.library.uu.nl/handle/1874/23898 ; URN:NBN:NL:UI:10-1874-23898 ; urn:isbn:978-90-393-4649-5 ; URN:NBN:NL:UI:10-1874-23898 ; http://dspace.library.uu.nl/handle/1874/23898.

Council of Science Editors:

Schooten CJMv. Von Willebrand Factor: clearance as regulator of plasma levels. [Doctoral Dissertation]. University Utrecht; 2007. Available from: http://dspace.library.uu.nl/handle/1874/23898 ; URN:NBN:NL:UI:10-1874-23898 ; urn:isbn:978-90-393-4649-5 ; URN:NBN:NL:UI:10-1874-23898 ; http://dspace.library.uu.nl/handle/1874/23898

.